Virpax Pharmaceuticals, Inc. (VRPX) NASDAQ

0.36

+0.043(+13.56%)

Updated at July 02 10:18AM

Currency In USD

Valuation

Market Cap40.42M
Enterprise Value38.9M
P/E Ratio-0.13
PEG Ratio-0
Price/Sales Ratio0
Price/Book Ratio-1.68
Enterprise/Revenue0
Enterprise/EBITDA0.09

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-7.76
Return On Equity6.92

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-12.08B
Net Income-12.07B
Diluted EPS-2,836.41

Balance Sheet

Total Cash1.51M
Total Cash/Share0.36
Total Debt0
Total Debt/Equity0
Current Ratio0.63
Book Value Per Share-0.21

Price History

52-Week Change-97.28
52-Week High84.75
52-Week Low0.14
Moving Average 50 Days0.26
Moving Average 200 Days7.38

Statistics

Average Volume63,200
Shares Outstanding1.24M
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:25
Last Split DateMarch 21, 2025